The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Ltd

BSE 532989 · NSE BAFNAPH · ISIN INE878I01022 · Group T · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹276.60

-3.25%

BSE close, 28 August 2026

Market cap

₹654.33 cr

2.4 cr shares · Micro cap

Free float

₹163.52 cr

as published

P/E · P/B

84.1× · 7.91×

EPS ₹3.29 · BV ₹34.97

FY25-26 rev / PAT

150.62 / 11.10

₹ cr, as filed

Filings, window

11

2 selected · 18%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹95.00 52-WK HIGH ₹296.00 ₹276.60 90% of range
Against 52-week high-6.6%
Against 52-week low+191.2%
Day change-3.25%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹3.29
Price / earnings84.07×
Price / book7.91×
Book value — derived, price ÷ P/B₹34.97
Return on equity9.41%
Operating margin10.51%
Net margin0.28%

Consistency check

P/B ÷ P/E, which must equal ROE
9.41%
ROE as published
9.41%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 26.58 0.08 0.03 10.51% 0.28%
Mar-26 · Q 42.24 2.75 1.16 12.57% 6.51%
FY25-26 150.62 11.10 4.69 13.75% 7.37%

Quarter on quarter

Revenue, quarter on quarter
-37.1%
Net profit, quarter on quarter
-97.1%
Operating margin, quarter on quarter
-206 bps

Disclosure profile 11 filings in the window

0 median 17.0 p75 · 25 sector max 52 11 22th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Results1
Selected sub-total2
Procedural
AGM / EGM4
Newspaper Publication2
Annual Report1
Board Meeting1
Book Closure1
Procedural sub-total9
Total11

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group T, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

11 filings · 2 selected · busiest 2026-08-11 and 2026-08-13

Filing rhythm · the twelve most recent

2026-08-052026-09-11

SelectedProcedural

Filings

11 in the window · 4 earlier on record

  1. 11 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    We herewith enclose the Voting Results of the 31st Annual General Meeting of the Company held on September 11, 2026 along with the Scrutinizer Report.

    AGM/EGM / AGM View filing →

  2. 11 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    We herewith enclose the Outcome / Proceedings of the 31st Annual General Meeting of the Company held on September 11, 2026.

    AGM/EGM / AGM View filing →

  3. 21 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    We herewith enclose the Newspaper Publication for the 31st Annual General Meeting of the Company published in 'Business Standard' and 'Makkal Kural' on August 20, 2026.

    Company Update / Newspaper Publication View filing →

  4. 19 August 2026 ·

    AGM / EGM

    Notice Of 31St Annual General Meeting Of The Company For The F.Y 2025-2026

    We herewith enclose the Notice of 31st Annual General Meeting of the Company scheduled to be held on Friday, September 11, 2026 at 10.00 A.M along with the Annual Report of the Company ....

    AGM/EGM / AGM View filing →

  5. 19 August 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    We herewith enclose the Annual Report of the Company for the F.Y 2025-2026.

    Others / Reg. 34 (1) Annual Report View filing →

  6. 14 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Publication for the Unaudited Financial Results of the Company for the Quarter ended June 30, 2026 as published in 'Business Standard' and 'Makkal Kural' on August 13, 2026.

    Company Update / Newspaper Publication View filing →

  7. 13 August 2026 ·

    Book Closure

    Book Closure For 31St Annual General Meeting

    We herewith enclose the intimation for Book Closure and Cut-Off dates for the purpose of 31st Annual General Meeting of the Company.

    Corp. Action / Book Closure View filing →

  8. 13 August 2026 ·

    AGM / EGM

    Shareholder Meeting - 31St AGM On September 11, 2026

    We hereby inform that the 31st Annual General Meeting (AGM) of the Company is scheduled to be held on Friday, September 11, 2026 at 10.00 A.M through Video Conferencing (VC) / Other Audio ....

    AGM/EGM / AGM View filing →

  9. 11 August 2026 ·

    Results

    Unaudited Financial Results For The Quarter Ended June 30, 2026

    We herewith enclose the Unaudited Financial Results for the Quarter ended June 30, 2026 as approved by the Board of Directors in its meeting held on August 11, 2026.

    Result / Financial Results View filing →

  10. 11 August 2026 ·

    Board Outcome

    Board Meeting Outcome for The Board Meeting Held On 11/08/2026

    We hereby inform you that the Board of Directors in their meeting held on August 11, 2026 inter-alia considered and approved i) Unaudited Financial Results of the Company for the Quarter ....

    Board Meeting / Outcome of Board Meeting View filing →

  11. 5 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Meeting Scheduled On August 11, 2026

    Bafna Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the Un-Audited Financial ....

    Board Meeting / Board Meeting View filing →

RSS feed for Bafna Pharmaceuticals Ltd · the 50 most recent filings